Neoleukin Therapeutics
Seattle, WA
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
neoleukin.comCompany Details
Founded
- 2019
Employees
- Between 50 - 100 employees
Raised
- $157,600,000
Headquarters Location
- Seattle, WA
Public
- Yes
Acquired
- Yes
CEO
Donna Cochener
Founders
- Jonathan Drachman
Company Collections
These are collections Neoleukin Therapeutics is a part of. Click on the collection name to view similar companies.
Neoleukin Therapeutics' Industries
Neoleukin Therapeutics Headquarters Location
1616 Eastlake Ave E 360, Seattle, WA 98102
Total Amount Raised: $157,600,000
Neoleukin Therapeutics Funding Rounds
Post Ipo Equity
$71,400,000
Post Ipo Equity
$86,200,000
IPO
Unknown
Funding info provided by Diffbot.
Neoleukin Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Neoleukin Therapeutics.